These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10425083)

  • 1. 2-(2-Phenylcyclopropyl)imidazolines: reversed enantioselective interaction at I(1) and I(2) imidazoline receptors.
    Quaglia W; Bousquet P; Pigini M; Carotti A; Carrieri A; Dontenwill M; Gentili F; Giannella M; Maranca F; Piergentili A; Brasili L
    J Med Chem; 1999 Jul; 42(15):2737-40. PubMed ID: 10425083
    [No Abstract]   [Full Text] [Related]  

  • 2. Imidazoline binding sites (IBS) profile modulation: key role of the bridge in determining I1-IBS or I2-IBS selectivity within a series of 2-phenoxymethylimidazoline analogues.
    Gentili F; Bousquet P; Brasili L; Dontenwill M; Feldman J; Ghelfi F; Giannella M; Piergentili A; Quaglia W; Pigini M
    J Med Chem; 2003 May; 46(11):2169-76. PubMed ID: 12747788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand binding to I2 imidazoline receptor: the role of lipophilicity in quantitative structure-activity relationship models.
    Pigini M; Bousquet P; Brasili L; Carrieri A; Cavagna R; Dontenwill M; Gentili F; Giannella M; Leonetti F; Piergentili A; Quaglia W; Carotti A
    Bioorg Med Chem; 1998 Dec; 6(12):2245-60. PubMed ID: 9925287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of new 2-(4,5-dihydro-1H-imidazol-2-yl)-3,4-dihydro-2H-1,4-benzoxazine derivatives.
    Touzeau F; Arrault A; Guillaumet G; Scalbert E; Pfeiffer B; Rettori MC; Renard P; Mérour JY
    J Med Chem; 2003 May; 46(10):1962-79. PubMed ID: 12723959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and pharmacological evaluation of imidazoline sites I1 and I2 selective ligands.
    Anastassiadou M; Danoun S; Crane L; Baziard-Mouysset G; Payard M; Caignard DH; Rettori MC; Renard P
    Bioorg Med Chem; 2001 Mar; 9(3):585-92. PubMed ID: 11310592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha2-adrenoreceptors profile modulation and high antinociceptive activity of (S)-(-)-2-[1-(biphenyl-2-yloxy)ethyl]-4,5-dihydro-1H-imidazole.
    Gentili F; Bousquet P; Brasili L; Caretto M; Carrieri A; Dontenwill M; Giannella M; Marucci G; Perfumi M; Piergentili A; Quaglia W; Rascente C; Pigini M
    J Med Chem; 2002 Jan; 45(1):32-40. PubMed ID: 11754577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-affinity binding of beta-carbolines to imidazoline I2B receptors and MAO-A in rat tissues: norharman blocks the effect of morphine withdrawal on DOPA/noradrenaline synthesis in the brain.
    Miralles A; Esteban S; Sastre-Coll A; Moranta D; Asensio VJ; García-Sevilla JA
    Eur J Pharmacol; 2005 Aug; 518(2-3):234-42. PubMed ID: 16061219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation, structure and affinity for imidazoline I2 receptors and alpha2-adrenoceptors of 1-[(4,5-dihydroimidazolidin-2-yl)imino]indan-2-ols.
    Kornicka A; Saczewski F; Tyacke RJ; Hudson AL; Nutt DJ
    Acta Pol Pharm; 2005; 62(6):497-502. PubMed ID: 16583991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of C2-alkylation, N-alkylation, and N,N'-dialkylation on the stability and estrogen receptor interaction of (4R,5S)/(4S,5R)-4,5-bis(4-hydroxyphenyl)-2-imidazolines.
    von Rauch M; Schlenk M; Gust R
    J Med Chem; 2004 Feb; 47(4):915-27. PubMed ID: 14761193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional studies of specific imidazoline-2 receptor ligands.
    Nutt DJ; French N; Handley S; Hudson A; Husbands S; Jackson H; Jordan S; Lalies MD; Lewis J; Lione L
    Ann N Y Acad Sci; 1995 Jul; 763():125-39. PubMed ID: 7677321
    [No Abstract]   [Full Text] [Related]  

  • 11. Imidazolines stimulate release of insulin from RIN-5AH cells independently from I1- and I2-imidazoline receptors.
    Olmos G; Kulkarni RN; Haque M; MacDermot J
    Ann N Y Acad Sci; 1995 Jul; 763():374-6. PubMed ID: 7677349
    [No Abstract]   [Full Text] [Related]  

  • 12. Design and synthesis of imidazoline derivatives active on glucose homeostasis in a rat model of type II diabetes. 2. Syntheses and biological activities of 1,4-dialkyl-, 1,4-dibenzyl, and 1-benzyl-4-alkyl-2-(4',5'-dihydro-1'H-imidazol-2'-yl)piperazines and isosteric analogues of imidazoline.
    Le Bihan G; Rondu F; Pelé-Tounian A; Wang X; Lidy S; Touboul E; Lamouri A; Dive G; Huet J; Pfeiffer B; Renard P; Guardiola-Lemaître B; Manéchez D; Pénicaud L; Ktorza A; Godfroid JJ
    J Med Chem; 1999 May; 42(9):1587-603. PubMed ID: 10229628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel ligands rationally designed for characterizing I2-imidazoline binding sites nature and functions.
    Gentili F; Cardinaletti C; Vesprini C; Ghelfi F; Farande A; Giannella M; Piergentili A; Quaglia W; Mattioli L; Perfumi M; Hudson A; Pigini M
    J Med Chem; 2008 Aug; 51(16):5130-4. PubMed ID: 18661965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coupling of I(1) imidazoline receptors to the cAMP pathway: studies with a highly selective ligand, benazoline.
    Greney H; Ronde P; Magnier C; Maranca F; Rascente C; Quaglia W; Giannella M; Pigini M; Brasili L; Lugnier C; Bousquet P; Dontenwill M
    Mol Pharmacol; 2000 Jun; 57(6):1142-51. PubMed ID: 10825384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imidazoline receptors: qualitative structure-activity relationships and discovery of tracizoline and benazoline. Two ligands with high affinity and unprecedented selectivity.
    Pigini M; Bousquet P; Carotti A; Dontenwill M; Giannella M; Moriconi R; Piergentili A; Quaglia W; Tayebati SK; Brasili L
    Bioorg Med Chem; 1997 May; 5(5):833-41. PubMed ID: 9208095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of an imidazopyridoindole at imidazoline I2 receptors.
    Glennon RA; Grella B; Tyacke RJ; Lau A; Westaway J; Hudson AL
    Bioorg Med Chem Lett; 2004 Jan; 14(2):527-9. PubMed ID: 14698196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-D and 3-D modeling of imidazoline receptor ligands: insights into pharmacophore.
    Carrieri A; Brasili L; Leonetti F; Pigini M; Giannella M; Bousquet P; Carotti A
    Bioorg Med Chem; 1997 May; 5(5):843-56. PubMed ID: 9208096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoradiographical distribution of imidazoline binding sites in monoamine oxidase A deficient mice.
    Anderson NJ; Seif I; Nutt DJ; Hudson AL; Robinson ES
    J Neurochem; 2006 Mar; 96(6):1551-9. PubMed ID: 16476082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel ligands for the investigation of imidazoline receptors and their binding proteins.
    Hudson AL; Tyacke RJ; Lalies MD; Davies N; Finn DP; Marti O; Robinson E; Husbands S; Minchin MC; Kimura A; Nutt DJ
    Ann N Y Acad Sci; 2003 Dec; 1009():302-8. PubMed ID: 15028604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LNP 906, the first high-affinity photoaffinity ligand selective for I1 imidazoline receptors.
    Urosevic D; Schann S; Ehrhardt JD; Bousquet P; Greney H
    Br J Pharmacol; 2004 Jun; 142(3):609-17. PubMed ID: 15178642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.